ZESTAGEN
Zestagen is a Swiss biotechnology company developing light chain mAbs against Extracellular Heat Shock Protein-90 (ehsp90). hsp90 is a validated pharmaceutical target. ehsp90 is implicated in cancer cell motility, migration and metastasis. It is detectable at the surface of several cancer cells but not of normal adult cells. Zestagen's mAbs bind ehsp90 at the surface of cancer cells (but not normal cells) leading to significant inhibition of metastasis in preclinical cancer animal models. Unlike small molecule hsp90 inhibitors which do not discriminate between the extracellular and intracellular hsp90 pool, Zestagen’s mAbs are predicted to display a superior therapeutic index in cancer patients.
ZESTAGEN
Industry:
Biotechnology Health Diagnostics Pharmaceutical
Founded:
2011-01-01
Address:
Epalinges, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.zestagen.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Amazon Nginx Amazon Frankfurt Region
Similar Organizations
Algonist Biotechnologies
Algonist Biotechnologies is a pre-clinical stage biotechnology company, developing novel small molecule therapeutics for chronic pain.
Roche France
Roche Diagnostics France is a biotechnology company that focuses on the research and development of pharmaceuticals and diagnostics.
Official Site Inspections
http://www.zestagen.com
- Host name: ec2-23-23-66-93.compute-1.amazonaws.com
- IP address: 23.23.66.93
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
